Clinical Trial Details
| Trial ID: | L2213 |
| Source ID: | NCT00330330 |
| Associated Drug: | Isis 113715 |
| Title: | Safety, Tolerability, and Activity of ISIS 113715 in People With Type 2 Diabetes Mellitus Who Have Not Received Prior Treatment |
| Acronym: | |
| Status: | COMPLETED |
| Study Results: | NO |
| Results: | |
| Conditions: | Type 2 Diabetes Mellitus |
| Interventions: | DRUG: ISIS 113715 |
| Outcome Measures: | Primary: To evaluate the safety and tolerability of ISIS 113715|To evaluate the pharmacokinetic profile of ISIS 113715|To evaluate the pharmacologic activity of ISIS 113715 | |
| Sponsor/Collaborators: | Sponsor: Ionis Pharmaceuticals, Inc. |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | PHASE2 |
| Enrollment: | 96 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT |
| Start Date: | 2003-02 |
| Completion Date: | 2006-08 |
| Results First Posted: | |
| Last Update Posted: | 2008-02-06 |
| Locations: | NZOZ Specjalistyczny Osrodek Internistyczno Diabetologiczny, Bialystok, 15-435, Poland|Prywatna Praktyka Lekarska, Radom, 26-600, Poland|Oddzial Chorob Wewnetrznych ze Stacja Dializ Szpital w Wolominie, Wolomin, 05-200, Poland|Chair of Endocrinology and Diabetology of the Faculty of Advenced Training for Physicians, Moscow, 109125, Russian Federation|Endocrinology Scientific Centre of RAMS, Moscow, 117036, Russian Federation|Medical Institution "Polyclinic OAOA Gazprom", Moscow, 117420, Russian Federation|Close Corporation "MEDSI", Moscow, 123056, Russian Federation|Chair of Endocrinology and Diabetology Central Clinical Hospital of the Ministry of Communications of RF, Moscow, 125315, Russian Federation|Moscow Regional Scientific-Research Clinical Institute named after I.F. Vladimirsky, Moscow, 129110, Russian Federation|Clinic of Therapy of Postgraduate Education named after N.S. Molchanov, St. Petersburg, 198013, Russian Federation |
| URL: | https://clinicaltrials.gov/show/NCT00330330 |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|